Coronary Thrombosis
13
0
0
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
23%
3 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (13)
Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus Control
The Study of CYP2C19 Genotype-Guided Clopidogrel Treatment Models
A MAajor RAdiation-based PCI Study in STEMI and NSTEMI
In-hospital Clinical Outcome of Deferred Stenting Versus Immediate Stenting in the Management of Acute STEMI Presenting With High Thrombus Burden.
Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside)
Independent OCT Registry on Very Late Bioresorbable Scaffold Thrombosis
Platelet Acetyl Coenzyme A Carboxylase Phosphorylation in Coronary Artery Disease
Periprocedural Myocardial Infarction: the Role of Human Neutrophil Peptide-1 to 3
Safety and Efficacy Study Comparing 3 New Types of Coronary Stents
OCT Evaluation of Healing of COMBO Stent
The SCRIPPS DES REAL WORLD Registry
Myeloid-Related Protein in Evaluation of Acute Chest Pain in the Emergency Departement
Monitoring Response to Antiplatelet Therapy